Journal article
Philadelphia Consensus on the Surgical Management of Xylazine-Associated Wounds in People Who Use Drugs
SurgiColl, v 3(2)
22 Jun 2025
Abstract
Xylazine-related wounds are increasingly presenting an addiction medicine and surgical dilemma in people who use drugs. Initially developed as a veterinary sedative, xylazine has been found increasingly added to illicitly manufactured fentanyl, reportedly to extend the duration of fentanyl intoxication. On the street, xylazine-laced fentanyl is known as “tranq,” “tranq dope,” and “zombie drug.” The management of xylazine-associated wounds needs multidisciplinary care. To better understand the scope of this new problem, review the best current evidence, and reach a consensus on best practices to manage xylazine-associated wounds, a formal consensus meeting was held, and the findings are presented here in this current concepts review.
Metrics
20 Record Views
Details
- Title
- Philadelphia Consensus on the Surgical Management of Xylazine-Associated Wounds in People Who Use Drugs
- Creators
- Asif M. Ilyas - Rothman InstituteSina Ramtin - Rothman InstituteErum N. Ilyas - Drexel UniversityMark K. Solarz - Temple University HospitalAndrew Miller - Thomas Jefferson University HospitalLisa Rae - Temple University HospitalJason Wink - Hospital of the University of PennsylvaniaRachel Haroz - Cooper University HospitalLara Weinstein - Thomas Jefferson University HospitalKatharine T. Criner-Woozley - Cooper University Hospital
- Publication Details
- SurgiColl, v 3(2)
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pediatrics; College of Medicine
- Other Identifier
- 991022061643304721